De novo phasing of two crystal forms of tryparedoxin II using the anomalous scattering from S atoms:: a combination of small signal and medium resolution reveals this to be a general tool for solving protein crystal structures

The de novo phasing of the structures of two crystal forms of tryparedoxin II from Crithidia fasciculata has been carried out using single-wavelength anomalous diffraction techniques exploiting only the small anomalous signal from the S atoms intrinsic to the native protein. Data were collected at 1.77 Angstrom wavelength, where the Bijvoet ratio is approximately 1.2%. Data collected to d(min) = 2.5 Angstrom from a crystal of form I, which has a diffraction limit of d(min) = 1.5 Angstrom and a solvent content of similar to 46%, produced readily interpretable electron-density maps. When these phases were extended to the resolution limit of the crystals, almost the entire model could be traced automatically. Crystals of form II have a much higher solvent content, similar to 72%, and a much lower diffraction limit than form I and at 1.77 Angstrom wavelength yielded data only to d(min) = 2.7 Angstrom. Despite the medium resolution of the data for this crystal form, it was possible both to determine the heavy-atom partial structure and then use it to produce, still at d(min) = 2.7 Angstrom, an excellent quality interpretable electron-density map. This was then improved by phase extension to the d(min) = 2.35 diffraction limits of a different crystal for which data were collected on a more intense beamline. The success of this latter structure solution markedly increases the potential use in macromolecular crystal structure determination of the anomalous signal available from S atoms that occur naturally in proteins and, as is discussed, has significant implications for structure determination in the high-throughput era.